Pfizer CEO: Increase R&D efficiency to boost innovation

07/28/2008 | Bloomberg

Drugmakers need to boost "efficiencies in research and development" to bolster innovation, Pfizer CEO Jeff Kindler told Bloomberg Television. Kindler's decision to divide Pfizer's R&D operation into smaller therapeutic units helped replenish its pipeline, which may have as many as 28 treatments in late-stage development by the end of 2009.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC